Inhibition of Adrenergic Receptors Reduces Genital HSV-1 Clinical Recurrences in Guinea Pigs
Viruses · 2026
DOI: 10.3390/v18101081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Jillian C Green und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical and Veterinary Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Receptors, Adrenergic, Herpes Simplex. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH NINDS.
Abstract (Originalsprache)
Herpes simplex virus 1 (HSV-1) establishes latency in both sensory and sympathetic neurons. Stress is strongly correlated with HSV-1 reactivation. The acute stress hormone epinephrine initiates HSV-1 reactivation in vitro upon activating at least two adrenergic receptors (ARs), including α2, β1, and/or β2-AR. To determine if blocking these receptors could reduce HSV-1 recurrences, we infected guinea pigs vaginally with HSV-1 (17+) and, after latency was established, treated them daily with atipamezole (specific α2-AR inhibitor), propranolol (nonspecific β-AR inhibitor), or atipamezole/propranolol combined. Clinical recurrences decreased in the treatment groups compared to untreated: atipamezole (29.3%, p = 0.123), propranolol (43.6%, p = 0.021), and atipamezole/propranolol (39.1%, p = 0.021). No significant differences were observed between groups in HSV-1 viral load in pelvic ganglia, or in transcription of the latency-associated transcript (LAT) in guinea pigs that were asymptomatic when euthanized, suggesting AR inhibitors did not affect latency. In guinea pigs euthanized during recurrences, viral DNA was similar between groups in sensory ganglia but reduced in sympathetic ganglia in treatment groups compared to untreated, suggesting that reactivation still occurred in sensory but was limited in sympathetic neurons in AR inhibitor-treated animals. The use of adrenergic beta blockers may be a useful therapeutic to reduce HSV-1 clinical recurrences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical and Veterinary Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA.
- Center for Emerging, Zoonotic, and Arthropod-Borne Pathogens, Virginia Tech, Blacksburg, VA 24061, USA.
- Department of Population Health Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061, USA.
ORCID-Profile: Greyson A Moore, Jonathan D Joyce, Andrea S Bertke
Förderung
- NINDS NIH HHS
- NIH NINDS
Zitieren
APA
Green, J. C., Moore, G. A., Irwin, M. D., Joyce, J. D., & Bertke, A. S. (2026). Inhibition of Adrenergic Receptors Reduces Genital HSV-1 Clinical Recurrences in Guinea Pigs. Viruses. https://doi.org/10.3390/v18101081
Vancouver
Green JC, Moore GA, Irwin MD, Joyce JD, Bertke AS. Inhibition of Adrenergic Receptors Reduces Genital HSV-1 Clinical Recurrences in Guinea Pigs. Viruses. 2026. doi:10.3390/v18101081
BibTeX
@article{Green2026,
author = {Green, Jillian C and Moore, Greyson A and Irwin, Matthew D and Joyce, Jonathan D and Bertke, Andrea S},
title = {Inhibition of Adrenergic Receptors Reduces Genital HSV-1 Clinical Recurrences in Guinea Pigs},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18101081}
}
EUVIMED